Daniel Hohl

6PUBLICATIONS
20CO-AUTHORS
Preventative health careMedical infection agents (incl. prions)Molecular targetsColloid and surface chemistryHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 28, 2026
Pharmacy-based triage to preselect high-risk individuals for skin cancer screening: A pilot study.

|Mar 26, 2026
[Pigmentary mosaicism: a literature review].

Selin Yener, Jean-Marc Good, Daniel Hohl

|Oct 09, 2023
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5.

Selina Gurri, Beat Siegenthaler, Michael Cangkrama

|Oct 27, 2021
Papillon-Lefevre syndrome treated by acitretin: case report and cytokine profile.

M Leuenberger, L Fischer, A Mylonas

|Sep 18, 2020
Birt-Hogg-Dubé syndrome.

Cécile Daccord, Jean-Marc Good, Marie-Anne Morren

|Apr 22, 2020
Oncogenic ALK drives tumorigenesis in cutaneous squamous cell carcinoma.

Marco Gualandi, Maria Iorio, Olivia Engeler

Pageof 1